JPMorgan and Guggenheim are acting as joint book running managers for the offering.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LRMR:
- Larimar Therapeutics price target raised to $14 from $12 at Citi
- Midday Fly By: Home Depot reports Q4 beat, AMD and Meta expand partnership
- Larimar Therapeutics announces FDA granted BTD to nomlabofusp
- FDA Grants Breakthrough Therapy Status to Larimar’s Nomlabofusp
- Larimar’s Pediatric Friedreich’s Ataxia Trial Termination: What Investors Should Know